期刊文献+

变形链球菌pacA和gtfB-cat与ctxB嵌合表达质粒的构建及表达 被引量:1

Construction and Expression of pacA and gtfB-cat of Streptococcus Mutans Fused with ctxB in Prokaryotic Cells
下载PDF
导出
摘要 目的:构建含变形链球菌表面蛋白A区编码基因(pacA)、葡糖基转移酶催化区编码基因(gtfB-cat)及霍乱毒素B亚单位编码基因(ctxB)的嵌合表达质粒并表达目的蛋白。方法:将目的基因pacA、gtfB-cat、ctxB克隆至原核克隆载体pET32-a(+)构建嵌合质粒pET-pacA-cat-ctxB,将其转入表达宿主菌E.coliBL21(DE3),并测量其表达情况。结果:构建的重组质粒经酶切、PCR鉴定及测序,证实目的基因均正确插入到载体pET-32a(+)中,插入的相位正确,未改变目的基因的阅读框架,经诱导后表达目的蛋白,分子质量大小与预期一致。结论:成功构建了嵌合质粒pET-pacA-cat-ctxB,且它们均在原核细胞内获得正确表达。 Objective: To construct the chimeric vector with the encoding gene of pacA of S.mutans, catalytic region in glucosyltransferase and cholera toxin B subnnit, and to testify its expression in Escherichia coll. Methods: The target genes pacA, gtfB-cat and etxB were cloned into procaryon cloning vectors pET32a (+) and constructed chimeric plasmid pET-pa- cA-cat-ctxB, which was transferred to the expression host strain E.coliBL21(DE3), and the expression was measured. Re- sults: The recombinant plasmid was inserted into the vector pET32a (+) correctly through the tests of restriction enzyme diges- tion, PCR identification and sequencing respectively. The correct phase for the insertion was confirmed. The reading frame of target genes didn't change. The recombinant plasmid can express target protein in E.coli host strain BL21 (DE3) after being induced by IPTG, and the molecular weight of the protein was consistent with the prediction. Conclusion: The recombinant plasmid pET-pacA-cat-ctxB was successfully constructed and it can be expressed in prokaryotic cells.
出处 《天津医药》 CAS 北大核心 2012年第6期533-536,共4页 Tianjin Medical Journal
基金 国家自然科学基金资助项目(项目编号:30160086) 贵州省科学技术基金项目(项目编号:黔科合J字[2006]2122号) 遵义医学院硕士启动基金项目(项目编号:遵医院发[2005]033号)
关键词 链球菌 酿脓 糖基转移酶类 霍乱毒素 膜蛋白质类 质粒 嵌合状态 原核细胞 streptococcus pyogenes glycosyltransferases cholera toxin membrane proteins plasmids chime- rism prokaryotic cells
  • 相关文献

参考文献10

  • 1樊明文.关于免疫防龋[J].中华口腔医学杂志,2006,41(5):279-281. 被引量:11
  • 2Paim S, Modesto A, Cury JA. Development and control of caries le- sions on the occlusal surface using a new in vivo caries model[J]. Pesqui Odontol Bras, 2003,17(2):189-195.
  • 3Mitoma M, Oho T, Michibata N.Passive immunization with bovine milk containing antibodies to a cell surface protein antigen-glucos- yhransferase fusion protein protects rats against dental caries [J]. Infect Immun ,2002,70(5):2721-2724.
  • 4杨德琴,刘天佳,曹福娴,杨锦波,刘建国.变形链球菌表面蛋白和葡糖基转移酶基因疫苗对唾液变形链球菌和牙菌斑的影响[J].四川大学学报(医学版),2003,34(3):494-496. 被引量:3
  • 5Fan MW, Bian Z, Peng ZX, et al. A DNA vaccine encoding a cell surface protein antigen of Streptococcus mutans protectsgnotobiotic rats from caries[J].J Dent Res,2002,81 (7):784-787.
  • 6曲云鹏,刘建国,杨德琴,麻健丰,陈代雄,柴巧学.变形链球菌葡糖基转移酶gtfB/CAT真核表达质粒的构建及表达[J].上海口腔医学,2008,17(3):289-292. 被引量:6
  • 7Taubman MA, Holmberg C J, Smith DJ. Diepitopic construct of func- tionally and epitopically.complementary peptides enhances immu- nogenicity, rReactivity with glucosyhransferase, and protection from dental caries [J]. Infect Immun, 2001,69(7):4210-4216.
  • 8杨锦波,刘天佳,周学东.变形链球菌葡糖基转移酶真核表达质粒pcDNA3-gtfB的构建[J].华西口腔医学杂志,2001,19(4):249-252. 被引量:10
  • 9Niu Y, Sun J, Fan M, et al. Construction of a new fusion anti-caries DNA vaccine[J]. J Dent Res, 2009,88(5):455-460.
  • 10Jeong H,Barbe V,Lee CH.Genome sequences of Escherichia coli B strains REL606 and BL21(DE3)[J]. J Mol Biol, 2009,394(4): 644-652.

二级参考文献26

共引文献24

同被引文献33

  • 1樊明文,许庆安,于飞,贾荣,郭继华,边专.靶向融合防龋DNA疫苗免疫大鼠的研究[J].中华口腔医学杂志,2004,39(6):459-462. 被引量:6
  • 2Matsumoto-Nakano M, Fujita K, Ooshima T. Comparison of glncan- binding proteins in eariogenicity of Streptococcus mutans [J]. Oral Micro Immun, 2007,22 (1) : 30-35.
  • 3Smith DJ,Taubman MA, King WF, et al. Immunological characteris- tics of a synthetic peptide associated with a catalytic domain of mu- tans streptococcal glucosyltransferase Eli. Infect Immun, 1994,62 (12) : 5470-5476.
  • 4CohenAD,BiyerJD,WeinerDB. Modulating the immune response to genetic immunization[J]. FAEB J, 1998, 12 (15) : 1611-1626.
  • 5Czcrkinsky C,Anjuere F, McGhee JR,et al. Mueosal immunity and tolerance: relevance to vaccine development[J]. Immun Rev, 1999, 170 (1) : 197-222.
  • 6Childers NK,Tong G, Michalek SM. Nasal immunization of humans with dehydrated liposomes containing Streptococcus mutans antigen [J]. Oral Micro Immun, 1997, 12 (6) : 329-335.
  • 7FSrg P, von Hoegen P, Dalemans W, et al. Superiority of the ear pin- na over muscle tissue as site for DNA vaccination [J']. Gene Ther, 1998, 5 (6) : 789-797.
  • 8Martin -Banderas L, Alvarez -Fuentes J, Duran -Lobato M, er al. Cannabinoid derivate-loaded PLGA nanocarriers for oral adminstra- tion: formulation, characterization, and cytotoxicity studies [J]. lnt J Nanomedicine, 2012,7: 5793-5806.
  • 9Periti P, Mazzei T, Mini E. Clinical pharmacokinetics of depot leu- prorelin [J]. Clin Pharmacokinet, 2002,41 (7) : 485-504.
  • 10He X,Jiang L, Wang F, et al. Augmented humoral and cellular im- mune responses to hepatitis B DNA vaccine adsorbed onto cationic micropartieles [J]. J Control Release.2005, 107 (2) : 357-372.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部